-
Loading metrics
Losartan Slows Pancreatic Tumor Progression and Extends Survival of SPARC-Null Mice by Abrogating Aberrant TGFβ Activation
- Shanna A. Arnold,
- Lee B. Rivera,
- Juliet G. Carbon,
- Jason E. Toombs,
- Chi-Lun Chang,
- Amy D. Bradshaw,
- Rolf A. Brekken
x
- Published: February 14, 2012
- https://doi.org/10.1371/journal.pone.0031384